Turkey
ICU Medical Inc (ICUI) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth Amidst Market Volatility
Revenue: $581 million, 10% growth on a constant currency basis, 9% on a reported basis.Adjusted EBITDA: $91 million.EPS: $1.56.Gross Margin: 36.6%.Free Cash Fl